Element Nutritional Sciences Inc (TSE:MUSL) has released an update.
Promino Nutritional Sciences Inc. has shown significant progress by repaying $0.7 million in accounts payable and achieving consecutive months of revenue for the first time in 18 months. The company has also initiated pre-clinical trials to test its product’s effectiveness in muscle retention for cancer patients undergoing chemotherapy, alongside expanding its sports nutrition brand with endorsements from professional athletes.
For further insights into TSE:MUSL stock, check out TipRanks’ Stock Analysis page.
